Insider Transactions in Q2 2024 at Entrada Therapeutics, Inc. (TRDA)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 13
2024
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
1,000
-0.3%
|
$16,000
$16.17 P/Share
|
|
Jun 03
2024
|
Peter S Kim Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,918
+10.25%
|
$71,508
$6.06 P/Share
|
|
May 20
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
9,675
-4.84%
|
$145,125
$15.19 P/Share
|
|
May 17
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
8,305
-3.99%
|
$124,575
$15.14 P/Share
|
|
May 17
2024
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
1,200
-0.35%
|
$18,000
$15.11 P/Share
|
|
May 16
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
1,000
-0.48%
|
$15,000
$15.0 P/Share
|
|
May 16
2024
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
1,800
-0.53%
|
$27,000
$15.0 P/Share
|
|
May 14
2024
|
Peter S Kim Director |
BUY
Open market or private purchase
|
Direct |
25,000
+21.29%
|
$350,000
$14.59 P/Share
|
|
May 09
2024
|
Peter S Kim Director |
BUY
Open market or private purchase
|
Direct |
2,200
+3.16%
|
$30,800
$14.25 P/Share
|
|
May 08
2024
|
Peter S Kim Director |
BUY
Open market or private purchase
|
Direct |
2,276
+3.37%
|
$31,864
$14.04 P/Share
|
|
Apr 08
2024
|
Peter S Kim Director |
BUY
Open market or private purchase
|
Direct |
2,600
+3.97%
|
$33,800
$13.57 P/Share
|